A team builds on COVID-19 mRNA vaccine technology to target specific pathways driving hepatocellular carcinoma — ScienceDaily
A team of researchers from Massachusetts General Hospital (MGH) and Brigham and Women’s Hospital (BWH) has reprogrammed the tumor microenvironment of liver cancer by using mRNA nanoparticles. This technology, similar…
